TELA Bio, Inc. financial data

Symbol
TELA on Nasdaq
Location
Malvern, PA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 388% % 8.2%
Quick Ratio 72% % -14%
Debt-to-equity 411% % -47%
Return On Equity -272% % 51%
Return On Assets -53% % 16%
Operating Margin -46% % 17%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 40,341,535 shares 2.4%
Common Stock, Shares, Outstanding 40,341,535 shares 63%
Entity Public Float $114,500,000 USD -53%
Common Stock, Value, Issued $40,000 USD 60%
Weighted Average Number of Shares Outstanding, Basic 45,421,795 shares 84%
Weighted Average Number of Shares Outstanding, Diluted 45,421,795 shares 84%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $77,055,000 USD 12%
Research and Development Expense $9,120,000 USD -3.7%
Selling and Marketing Expense $62,649,000 USD -7.7%
General and Administrative Expense $15,499,000 USD 2.1%
Operating Income (Loss) $35,461,000 USD 6.8%
Nonoperating Income (Expense) $3,596,000 USD -3.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $39,057,000 USD 17%
Income Tax Expense (Benefit) $33,000 USD
Net Income (Loss) Attributable to Parent $38,998,000 USD 6.1%
Earnings Per Share, Basic 0 USD/shares 50%
Earnings Per Share, Diluted 0 USD/shares 50%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $29,713,000 USD 72%
Inventory, Net $11,558,000 USD -15%
Assets, Current $56,048,000 USD 27%
Deferred Income Tax Assets, Net $62,000 USD
Property, Plant and Equipment, Net $2,213,000 USD -8.7%
Operating Lease, Right-of-Use Asset $1,560,000 USD -13%
Intangible Assets, Net (Excluding Goodwill) $1,454,000 USD -21%
Other Assets, Noncurrent $1,131,000 USD -58%
Assets $61,587,000 USD 16%
Accounts Payable, Current $2,373,000 USD -4.3%
Employee-related Liabilities, Current $6,760,000 USD -14%
Accrued Liabilities, Current $14,604,000 USD 1.6%
Liabilities, Current $16,977,000 USD 0.71%
Operating Lease, Liability, Noncurrent $1,400,000 USD -18%
Other Liabilities, Noncurrent $1,559,000 USD 6.8%
Liabilities $60,030,000 USD 1.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax $91,000 USD -39%
Retained Earnings (Accumulated Deficit) $388,520,000 USD -11%
Stockholders' Equity Attributable to Parent $1,557,000 USD
Liabilities and Equity $61,587,000 USD 16%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $9,725,000 USD 32%
Net Cash Provided by (Used in) Financing Activities $116,000 USD -307%
Net Cash Provided by (Used in) Investing Activities $138,000 USD -97%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 40,341,535 shares 63%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $9,837,000 USD -2.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $29,963,000 USD 71%
Interest Paid, Excluding Capitalized Interest, Operating Activities $1,370,000 USD 16%
Deferred Tax Assets, Valuation Allowance $76,782,000 USD 8%
Deferred Tax Assets, Gross $77,678,000 USD 7.9%
Operating Lease, Liability $1,935,000 USD -14%
Depreciation $172,000 USD 24%
Payments to Acquire Property, Plant, and Equipment $32,000 USD -89%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $39,056,000 USD 5.9%
Lessee, Operating Lease, Liability, to be Paid $3,135,000 USD -16%
Property, Plant and Equipment, Gross $7,001,000 USD 11%
Operating Lease, Liability, Current $521,000 USD -6.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two $557,000 USD -4%
Lessee, Operating Lease, Liability, to be Paid, Year One $580,000 USD -3.5%
Deferred Income Tax Expense (Benefit) $52,000 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,200,000 USD -19%
Lessee, Operating Lease, Liability, to be Paid, Year Three $570,000 USD 2.3%
Deferred Tax Assets, Operating Loss Carryforwards $66,265,000 USD 7.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $583,000 USD 2.3%
Additional Paid in Capital $389,946,000 USD 14%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $896,000 USD -2.6%
Share-based Payment Arrangement, Expense $4,073,000 USD -9.8%
Interest Expense $5,309,000 USD 21%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%